Interestingly, for the pre-germline-reset parental antibody ETA-005, the reactivity against FOLR1 KO cells was already reduced in comparison to WT cells indicating that the molecular design itself already leads to an increased specificity towards cells expressing the tumor anchor FOLR1. This evidence concerns the gene FOLR1 and neoplasm.